Initial Management of Newly Diagnosed HIV Infection and Active Tuberculosis: anti-Tuberculosis Therapy

You answered:

	Given the high prevalence of drug resistance among patients co-infected with TB and HIV, anti-TB therapy should not be started until drug susceptibilities are known for her strain of TB.

This answer is incorrect. Although patients co-infected with HIV and TB should ideally be screened for drug-resistant TB at the time of diagnosis, initiation of TB therapy should not be delayed.

Choose another answer:

	Anti-tuberculosis therapy should be started immediately, consisting of a four-drug regimen of rifampicin, isoniazid, pyrazinamide, and ethambutol.
	The duration of therapy for this HIV-infected patient with pulmonary TB should be 18 months.
	Rapid HIV serology test result should be confirmed prior to initiation of anti-TB therapy, since she will need different medications to treat her pulmonary TB therapy if she is co-infected with HIV.

[Back to Case Question | Go to Correct Answer]

Resource-Limited Settings

Initial Management of Newly Diagnosed HIV Infection and Active Tuberculosis: anti-Tuberculosis Therapy